Efficacy and safety of Hydrocortison-POS N1% and 2.5% versus Ficortril 0.5% in the treatment of acute inflammation of the ocular surface or adnexa for which steroid treatment is indicated

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2013
This article has no abstract
Epistemonikos ID: 589e7a02ff2270514c492b61b22c0e944f5959f8
First added on: Oct 16, 2021